INO Trading Below Director's Recent Buy Price
July 12, 2016 at 13:43 PM EDT
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on June 28, Inovio Pharmaceuticals Inc.'s Director, Morton Collins, invested $91,309.00 into 10,000 shares of INO, for a cost per share of $9.13..